Although neither of the two antidiabetic drugs used as prediabetes treatment, metformin and liraglutide, were able to reverse HFHSD-induced DM2, metformin was the superior intervention over liraglutide due to improved central leptin sensitivity and peripheral insulin sensitivity in females. This evidence concerns the gene LEP and myotonic dystrophy type 2.